Long Acting Somatostatin Analogue: Clinical Potential for Gastrointestinal Disease
Name somatostatin is found throughout the gastrointestinal tract and has a wide variety of biological actions. Nevertheless, its short biological half-life and limited stability necessitate its use via continuous parenteral infusion and, thus, limits its therapeutic usefulness The development of lon...
Saved in:
| Main Author: | Richard N. Fedorak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1989-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/1989/398524 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-Term Results of Cabergoline Add-on Long-Acting Somatostatin Analogue Therapy in Acromegaly Patients
by: Mehmet Muhittin Yalçın, et al.
Published: (2024-10-01) -
Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study
by: Ming Shen, et al.
Published: (2018-01-01) -
Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease: a systematic review and meta-analysis
by: Mark T Mills, et al.
Published: (2020-01-01) -
Expression of Somatostatin Receptor 2 in Somatotropinoma Correlated with the Short-Term Efficacy of Somatostatin Analogues
by: Wenjuan Liu, et al.
Published: (2017-01-01) -
Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors
by: Callisia N. Clarke, et al.
Published: (2023-12-01)